204 related articles for article (PubMed ID: 16119006)
1. Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2005; 15(2):87-94. PubMed ID: 16119006
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen.
Lant NJ; McKeown P; Timoney MC; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2001 Feb; 16(1):49-55. PubMed ID: 11762644
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol.
Lant NJ; McKeown P; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2000 Aug; 15(4):295-302. PubMed ID: 11200505
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimelanoma activity of tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Pearson VC; Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2003; 13(11):503-12. PubMed ID: 12812364
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimelanoma activity of reversed amide analogues of N-acetyl-4-S-cysteaminylphenol.
Nicoll K; Robertson J; Lant N; Kelland LR; Rogers PM; Robins DJ
Oncol Res; 2006; 16(2):97-106. PubMed ID: 16898270
[TBL] [Abstract][Full Text] [Related]
7. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
[TBL] [Abstract][Full Text] [Related]
8. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
Prezioso JA; Wang N; Bloomer WD
Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
[TBL] [Abstract][Full Text] [Related]
10. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
11. Analogues of N-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitors of tyrosinase and melanin formation.
Criton M; Le Mellay-Hamon V
Bioorg Med Chem Lett; 2008 Jun; 18(12):3607-10. PubMed ID: 18501598
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
[TBL] [Abstract][Full Text] [Related]
13. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.
Ullah S; Kang D; Lee S; Ikram M; Park C; Park Y; Yoon S; Chun P; Moon HR
Eur J Med Chem; 2019 Jan; 161():78-92. PubMed ID: 30347330
[TBL] [Abstract][Full Text] [Related]
15. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
Prezioso JA; Epperly MW; Wang N; Bloomer WD
Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.
Kern DH; Shoemaker RH; Hildebrand-Zanki SU; Driscoll JS
Cancer Res; 1988 Sep; 48(18):5178-82. PubMed ID: 3136917
[TBL] [Abstract][Full Text] [Related]
17. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Alena F; Iwashina T; Gili A; Jimbow K
Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
[TBL] [Abstract][Full Text] [Related]
18. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
Palchaudhuri R; Hergenrother PJ
Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K
Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and antiproliferative activity screening of (+/-)-aplicyanins A, B and E and related analogues.
Sísa M; Pla D; Altuna M; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2009 Oct; 52(20):6217-23. PubMed ID: 19827832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
